Key points are not available for this paper at this time.
PURPOSE: Ga-OncoFAP) radiolabeling, benchmark its properties in preclinical imaging, and evaluate its application in clinical PET scanning. METHODS: Ga-OncoFAP combined with PET/CT and PET/MRI. RESULTS: up to 20.0). CONCLUSION: Ga-OncoFAP as a powerful alternative to currently available FAP tracers.
Backhaus et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: